HOME Top Market Reports Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021

Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: BT 3682

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The rat model market is projected to reach USD 588.9 Million by 2021 from USD 387.7 Million in 2016, growing at a CAGR of 8.7% in the next five years (2016 to 2021). Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to less stringent regulations on the use of animal models for research, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical and biotechnology R&D activities.

In 2016, North America is expected to account for the largest share of the global rat model market. North America’s leadership in this market can be attributed to the revised funding plans by NIH to enhance reproducibility of results, rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada.

On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment

On the basis of service, the market is segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model-in-licensing, and other services (surgical services, line rescue services, and in vivo pharmacology services). In 2016, the breeding services segment is expected to command the largest share of the global market. However, the cryopreservation services segment is expected to grow at the highest CAGR during the forecast period.

On the basis of therapeutic area, the market is segmented into toxicology, oncology, immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases, cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the toxicology segment is expected to command the largest share of the global rat model market.

On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN). In 2016, the CRISPR segment is expected to command the largest share of the global market.

On the basis of end user, the rat model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global market. However, the academic & research institutions segment is expected to grow at the highest CAGR during the forecast period.

Charles River Laboratories International, Inc. (U.S.), Envigo (U.K.), and Taconic Biosciences, Inc. (U.S.) are the key players in the global rat model market. Other companies include Biomere (U.S.), genOway SA (France), Janvier Labs (France), Laboratory Corporation of America Holdings (U.S.), Transviragen, Inc. (U.S.), Transposagen Biopharmaceuticals, Inc. (U.S.), and Horizon Discovery Group plc (U.K.).

Stakeholders of the Rat Model Market 

  • Rat Model and Service Companies
  • Government and Private Research Institutes
  • Manufacturers and Suppliers of Animal Care Products
  • Academic & Research Institutes
  • Venture Capitalists
  • Medical Research Centers
  • Animal Care Associations
  • Public and Private Animal Health Agencies

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the global rat model market into the following segments:

Rat Model Market, by Model Type

  • Outbred Rats
  • Inbred Rats
  • Knockout/Genetically Modified Rats
  • Hybrid/Congenic Rats
  • Conditioned/Surgically Modified Rats
  • Immunodeficient Rats

Rat Model Market, by Service

  • Breeding
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Model-in-licensing
  • Genetic Testing
  • Other Services

Rat Model Market, by Therapeutic Area

  • Toxicology
  • Oncology
  • Immunology and Inflammation
  • Neurology
  • Diabetes
  • Other Therapeutic Areas

Rat Model Market, by Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies

Rat Model Market, by Care Product

  • Cages
  • Feed
  • Bedding
  • Other Care Products

Rat Model Market, by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Rat Model Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Russia
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Methodology
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Methodology
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 35)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 43)
    4.1 Rat Model Market Overview
    4.2 Regional Analysis: Global Rat Care Product Market, By Type
    4.3 Global Rat Model Market, By Therapeutic Area, 2016 & 2021
    4.4 Regional Snapshot of the Global Rat Model Market

5 Market Overview (Page No. - 46)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Advancements in Gene Editing Tools Set to Augment the Demand for Rat Models
                    5.2.1.2 Advantages Offered By Rats Over Mice
                    5.2.1.3 Continuous Support in the Form of Investments and Grants
                    5.2.1.4 Increased Demand for Personalized Humanized Rat Models Due to Growing Consumption of Personalized Medicines
                    5.2.1.5 Increase in R&D Activities Carried Out By Pharmaceutical and Biotechnology Companies
           5.2.2 Restraints
                    5.2.2.1 Regulations & Laws Formulated for Ethical Use of Animals
                               5.2.2.1.1 the Animal Welfare Act (AWA)
                               5.2.2.1.2 Public Health Service Policy (PHS) on Humane Care and Use of Laboratory Animals
                    5.2.2.2 Increased Benefits Offered By Cryopreservation
           5.2.3 Opportunities
                    5.2.3.1 Increased Production of Monoclonal Antibodies
                    5.2.3.2 Rising Demand of Humanized Rat Models
           5.2.4 Challenges
                    5.2.4.1 Advancements in Zebrafish Model Development
                    5.2.4.2 Development of Methods Alternative to Animal Testing

6 Clinical Trials & Research Studies Assessment (Page No. - 56)
    6.1 Introduction
    6.2 Clinical Trials
    6.3 Research Studies

7 Global Rat Model Market, By Model Type (Page No. - 65)
    7.1 Introduction
    7.2 Outbred Rats
    7.3 Inbred Rats
    7.4 Knockout/Genetically Engineered Rats
    7.5 Hybrid/Congenic Rats
    7.6 Conditioned/Surgically Modified Rats
    7.7 Immunodeficient Rats

8 Global Rat Model Market, By Service (Page No. - 74)
    8.1 Introduction
    8.2 Breeding
    8.3 Cryopreservation
    8.4 Quarantine
    8.5 Rederivation
    8.6 Model In-Licensing
    8.7 Genetic Testing
    8.8 Others
           8.8.1 Surgical Services
           8.8.2 Line Rescue Services
           8.8.3 In Vivo Pharmacology Services

9 Global Rat Model Market, By Technology (Page No. - 85)
    9.1 Introduction
    9.2 Crispr
    9.3 Microinjection
    9.4 Embryonic Stem Cell Injection
    9.5 Nuclear Transfer
    9.6 Other Technologies

10 Global Rat Model Market, By Therapeutic Area (Page No. - 94)
     10.1 Introduction
     10.2 Toxicology
     10.3 Oncology
             10.3.1 New Product Launches for Oncology Research
             10.3.2 Continuous Grants/Funds to Support Cancer Research Studies
     10.4 Immunology and Inflammation
     10.5 Neurology
     10.6 Diabetes
     10.7 Others

11 Global Rat Model Market, By End User (Page No. - 106)
     11.1 Introduction
     11.2 Pharmaceutical & Biotechnology Companies
     11.3 Academic & Research Institutions
     11.4 Contract Research Organizations (CRO)

12 Global Rat Model Market, By Care Product (Page No. - 112)
     12.1 Introduction
     12.2 Cages
     12.3 Feed
     12.4 Bedding
     12.5 Other Care Products

13 Global Rat Model Market, By Region (Page No. - 119)
     13.1 Introduction
     13.2 North America
             13.2.1 U.S.
                        13.2.1.1 Growing Biomedical Research in the U.S.
                        13.2.1.2 Preclinical Activities By Cros and Pharmaceutical R&D
                        13.2.1.3 Continued and Responsible Use of Animals Ensured By Animal Care Organizations
                        13.2.1.4 Development of Biosimilars Product Boosting the Demand for Preclinical Services
                        13.2.1.5 Monoclonal Antibody Production to Augment the Use of Rat Models
                        13.2.1.6 Partnership Between Cros and Pharmaceutical Companies
             13.2.2 Canada
                        13.2.2.1 Growing Stem Cell Research Activities in Canada
                        13.2.2.2 Government Support for Development of Protein Drugs is Expected to Drive the Market
     13.3 Europe
             13.3.1 Germany
                        13.3.1.1 Launch of Pro-Test Deutschland
                        13.3.1.2 Flourishing Biotechnology Industry
             13.3.2 U.K.
                        13.3.2.1 Investors Demand Strong Statistics for Animal Studies in the U.K.
                        13.3.2.2 Increase in Cell Therapy Preclinical Research
             13.3.3 France
                        13.3.3.1 Funding for Rare Disease Projects in France
             13.3.4 Russia
                        13.3.4.1 Growing Biomedical Industry in Russia
             13.3.5 Rest of Europe
                        13.3.5.1 Growth in Biotech and Pharma Sector of Italy
                        13.3.5.2 Growing Investments in Research By Sweden & Denmark
                        13.3.5.3 Focus on Rare Disease Research Projects
                        13.3.5.4 Growth in Biosimilars Market to Lead to Increased Preclinical Activities
     13.4 Asia-Pacific
             13.4.1 China
                        13.4.1.1 International Alliances for R&D Activities in China
                        13.4.1.2 Initiatives to Reduce Longer Approval Times
                        13.4.1.3 Intellectual Property (Ip) Breaches, A Challenge for the China Market
                        13.4.1.4 Mandatory Animal Testing for All Pharmaceutical Drugs and Cosmetics in China
                        13.4.1.5 Increasing Investments From Government and Private Sectors in China’s Life Sciences Sector
             13.4.2 Japan
                        13.4.2.1 Growth in Biomedical and Medical Research in Japan
                        13.4.2.2 Research in Regenerative Medicine
                        13.4.2.3 Focus on Cancer Research and Treatment
             13.4.3 India
                        13.4.3.1 Growth of the Pharmaceutical Industry in India
                        13.4.3.2 Development of Bio-Clusters to Boost India’s Biotechnology
                        13.4.3.3 Growing Presence of Global Players
                        13.4.3.4 Shift of Outsourcing Preclinical Activities From India to European Nations
                        13.4.3.5 Weak Intellectual Property Environment in India
                        13.4.3.6 Limited Infrastructural Facilities in India, A Major Hindrance for Growth of the Rat Model Market
             13.4.4 Rest of Asia-Pacific
                        13.4.4.1 Ongoing Biomedical Research Activities in Australia to Strengthen the Market
                        13.4.4.2 Growth in Translational and Biomedical Research in Singapore
                        13.4.4.3 Increase in Animal Research in Malaysia
                        13.4.4.4 Government Support for Strong Academic and Commercial R&D Activities in Taiwan
                        13.4.4.5 Rising Pharmaceutical and Biotechnology R&D Activities in Korea
     13.5 Rest of the World
             13.5.1 Pharmaceutical, Biotechnology, and Research Industries in Brazil to Drive Market Growth
             13.5.2 Favorable Business Environment for Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE
             13.5.3 Increasing Investments in Mexico

14 Competitive Landscape (Page No. - 194)
     14.1 Overview
     14.2 Market Share Analysis
             14.2.1 Introduction
             14.2.2 Charles River Laboratories International, Inc. (U.S.)
             14.2.3 Envigo (U.K.)
             14.2.4 Taconic Biosciences, Inc. (U.S.)
     14.3 Competitive Situation and Trends
     14.4 Agreements, Collaborations, and Partnerships
     14.5 Acquisitions
     14.6 Expansions
     14.7 New Product Launches
     14.8 Other Strategies

15 Company Profiles (Page No. - 206)
(Overview, Products and Services, Financials, Strategy & Development)*
     15.1 Introduction
     15.2 Charles River Laboratories International, Inc.
     15.3 Taconic Biosciences, Inc.
     15.4 Envigo
     15.5 Laboratory Corporation of America Holdings
     15.6 Janvier Labs
     15.7 Genoway S.A.
     15.8 Biomere
     15.9 Transposagen Biopharmaceuticals, Inc.
     15.10 Horizon Discovery Group PLC
     15.11 Transviragen, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

16 Appendix (Page No. - 237)
     16.1 Discussion Guide
     16.2 Other Developments
             16.2.1 Charles River Laboratories International, Inc.
             16.2.2 Taconic Biosciences, Inc.
             16.2.3 Envigo
             16.2.4 Laboratory Corporation of America Holdings
             16.2.5 Genoway S.A.
             16.2.6 Horizon Discovery Group PLC
     16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     16.4 Introducing RT: Real-Time Market Intelligence
     16.5 Available Customizations
     16.6 Related Reports
     16.7 Author Details


List of Tables (132 Tables)

Table 1 Indicative List of Clinical Trials Conducted on Rat Models
Table 2 Indicative List of Research Studies Conducted on Rat Models
Table 3 Global Rat Model Market, By Model Type, 2014-2021 (USD Million)
Table 4 Market for Outbred Rats, By Region, 2014-2021 (USD Thousand)
Table 5 Market for Inbred Rats, By Region, 2014-2021 (USD Thousand)
Table 6 Market for Knockout/Genetically Engineered Rats, By Region, 2014-2021 (USD Thousand)
Table 7 Market for Hybrid/Congenic Rats, By Region, 2013-2021 (USD Thousand)
Table 8 Market for Conditioned/Surgically Modified Rats, By Region, 2013-2021 (USD Thousand)
Table 9 Market for Immunodeficient Rats, By Region, 2013-2021 (USD Thousand)
Table 10 Global Market, By Service, 2014-2021 (USD Million)
Table 11 Market for Breeding, By Region, 2014-2021 (USD Thousand)
Table 12 Market for Cryopreservation, By Region, 2014-2021 (USD Thousand)
Table 13 Market for Quarantine, By Region, 2014-2021 (USD Thousand)
Table 14 Market for Rederivation, By Region, 2014-2021 (USD Thousand)
Table 15 Market for Model In-Licensing, By Region, 2014-2021 (USD Thousand)
Table 16 Market for Genetic Testing, By Region, 2014-2021 (USD Thousand)
Table 17 Market for Others , By Region, 2014-2021 (USD Thousand)
Table 18 Global Market, By Technology, 2014-2021 (USD Million)
Table 19 Market for Crispr, By Region, 2014-2021 (USD Thousand)
Table 20 Market for Microinjection, By Region, 2014-2021 (USD Thousand)
Table 21 Market for Embryonic Stem Cell Injection, By Region, 2014-2021 (USD Thousand)
Table 22 Market for Nuclear Transfer, By Region, 2014-2021 (USD Thousand)
Table 23 Market for Other Technologies, By Region, 2014-2021 (USD Thousand)
Table 24 Global Market, By Therapeutic Area, 2014-2021 (USD Million)
Table 25 Market in Toxicology, By Region, 2014-2021 (USD Thousand)
Table 26 List of Cancer Research Studies Using Rat Models
Table 27 Market in Oncology, By Region, 2013-2021 (USD Thousand)
Table 28 Market in Immunology and Inflammation, By Region, 2014-2021 (USD Thousand)
Table 29 Indicative List of Neurological Research Studies Using Rat Model
Table 30 Market in Neurology, By Region, 2014-2021 (USD Thousand)
Table 31 Market in Diabetes, By Region, 2014-2021 (USD Thousand)
Table 32 Market in Others, By Region, 2014-2021 (USD Thousand)
Table 33 Global Market, By End User, 2014-2021 (USD Million)
Table 34 Market for Pharmaceutical & Biotechnology Companies, By Region, 2014-2021 (USD Thousand)
Table 35 Market for Academic & Research Institutions, By Region, 2014-2021 (USD Thousand)
Table 36 Market for Contract Research Organizations, By Region, 2014-2021 (USD Thousand)
Table 37 Global Rat Care Product Market, By Type, 2014-2021 (USD Thousand)
Table 38 Rat Care Product Market for Cages, By Region, 2014-2021 (USD Thousand)
Table 39 Rat Care Product Market for Feed, By Region, 2014-2021 (USD Thousand)
Table 40 Rat Care Product Market for Bedding, By Region, 2014-2021 (USD Thousand)
Table 41 Rat Care Product Market for Other Care Products, By Region, 2014-2021 (USD Thousand)
Table 42 Market, By Region, 2014–2021 (USD Million)
Table 43 North America: Market, By Country, 2014–2021 (USD Million)
Table 44 North America: Market, By Model Type, 2014–2021 (USD Million)
Table 45 North America: Market, By Service, 2014–2021 (USD Thousand)
Table 46 North America: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 47 North America: Market, By Technology, 2014–2021 (USD Thousand)
Table 48 North America: Market, By End User, 2014–2021 (USD Million)
Table 49 North America: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 50 Nih Funding for Projects Related to Animal Models
Table 51 Associations Directly Related to the Animal Model Market
Table 52 Associations Indirectly Related to the Animal Model Market
Table 53 U.S.: Market, By Model Type, 2014–2021 (USD Million)
Table 54 U.S.: Market, By Service, 2014–2021 (USD Million)
Table 55 U.S.: Market, By Therapeutic Area, 2014–2021 (USD Million)
Table 56 U.S.: Market, By Technology, 2014–2021 (USD Thousand)
Table 57 U.S.: Market, By End User, 2014–2021 (USD Million)
Table 58 Canada: Market, By Model Type, 2014–2021 (USD Thousand)
Table 59 Canada: Market, By Service, 2014–2021 (USD Thousand)
Table 60 Canada: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 61 Canada: Market, By Technology, 2014–2021 (USD Thousand)
Table 62 Canada: Market, By End User, 2014–2021 (USD Thousand)
Table 63 Europe: Market, By Country, 2014–2021 (USD Thousand)
Table 64 Europe: Market, By Model Type, 2014–2021 (USD Million)
Table 65 Europe: Market, By Service, 2014–2021 (USD Thousand)
Table 66 Europe: Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 67 Europe: Market, By Technology, 2014–2021 (USD Thousand)
Table 68 Europe: Market, By End User, 2014–2021 (USD Million)
Table 69 Europe: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 70 Germany: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 71 Germany: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 72 Germany: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 73 Germany: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 74 Germany: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 75 U.K.: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 76 U.K.: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 77 U.K.: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 78 U.K.: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 79 U.K.: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 80 France: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 81 France: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 82 France: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 83 France: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 84 France: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 85 Russia: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 86 Russia: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 87 Russia: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 88 Russia: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 89 Russia: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 90 RoE: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 91 RoE: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 92 RoE: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 93 RoE: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 94 RoE: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 95 Asia-Pacific: Rat Model Market, By Country, 2014–2021 (USD Million)
Table 96 Asia-Pacific: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 97 Asia-Pacific: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 98 Asia-Pacific: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 99 Asia-Pacific: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 100 Asia-Pacific: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 101 Asia-Pacific: Rat Care Products Market, By Care Product, 2014–2021 (USD Thousand)
Table 102 China: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 103 China: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 104 China: Rat Model Market Size, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 105 China: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 106 China: Rat Model Market, By End User, 2014–2021 (USD Million)
Table 107 Japan: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 108 Japan: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 109 Japan.: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 110 Japan: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 111 Japan: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 112 India: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 113 India: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 114 India: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 115 India: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 116 India: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 117 Rest of APAC: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 118 Rest of APAC: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 119 Rest of APAC: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 120 Rest of APAC: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 121 Rest of APAC: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 122 RoW: Rat Model Market, By Model Type, 2014–2021 (USD Thousand)
Table 123 RoW: Rat Model Market, By Service, 2014–2021 (USD Thousand)
Table 124 RoW: Rat Model Market, By Therapeutic Area, 2014–2021 (USD Thousand)
Table 125 RoW: Rat Model Market, By Technology, 2014–2021 (USD Thousand)
Table 126 RoW: Rat Model Market, By End User, 2014–2021 (USD Thousand)
Table 127 RoW: Rat Care Product Market, By Care Product, 2014–2021 (USD Thousand)
Table 128 Agreements, Collaborations, and Partnerships, 2013–2016
Table 129 Acquisitions, 2013–2016
Table 130 Expansions, 2013–2016
Table 131 New Product Launches, 2013–2016
Table 132 Other Strategies, 2013–2016


List of Figures (47 Figures)

Figure 1 Global Rat Model Market: Research Methodology
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Global Rat Model Market, By Therapeutic Area (2016)
Figure 9 Global Rat Model Market, By Model Type
Figure 10 Global Rat Model Market, By Service
Figure 11 Global Rat Model Market, By End User
Figure 12 Global Rat Model Market, By Technology
Figure 13 Global Rat Model Market, By Care Product
Figure 14 The Asia-Pacific Rat Model Market to Witness the Highest Growth During the Forecast Period
Figure 15 Attractive Opportunities in the Global Rat Model Market
Figure 16 North America Dominated the Global Rat Care Product Market in 2016
Figure 17 The Toxicology Segment to Account for the Largest Share of the Global Rat Model Market During the Forecast Period
Figure 18 The Asia-Pacific Region to Witness the Highest Growth in the Global Rat Model Market From 2016 to 2021
Figure 19 Drivers, Restraints, Opportunities, and Challenges
Figure 20 Clinical Trials Using Rat Models, By Indication
Figure 21 Clinical Trials Using Rat Models, By Phase
Figure 22 Research Studies Using Rat Models, By Indication
Figure 23 Based on Model Type, the Outbred Rats Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 24 Based on Service, the Breeding Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 25 Rat Model Market, By Technology, 2016-2021
Figure 26 Based on Therapeutic Area, the Toxicology Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 27 Based on End User, the Pharmaceutical & Biotechnology Companies Segment is Estimated to Dominate the Rat Model Market in 2016
Figure 28 Based on Care Product, the Cages Segment is Estimated to Dominate the Rat Care Products Market in 2016
Figure 29 North America Dominates the Market for Rat Model Products
Figure 30 North America: Rat Model Market Snapshot
Figure 31 Europe: Rat Model Market Snapshot
Figure 32 Number of Cell Therapy Preclinical Studies Listed in the U.K. Preclinical Research Database , 2013-2016
Figure 33 Asia-Pacific: Rat Model Market Snapshot
Figure 34 Rest of the World: Rat Model Market Snapshot
Figure 35 Major Players Focusing on Inorganic Growth Strategies
Figure 36 Market Share Analysis, By Key Player, 2015
Figure 37 Agreements, Collaborations, and Partnerships Was the Key Growth Strategy Adopted By Market Players
Figure 38 Agreements, Collaborations, and Partnerships, By Company (2013–2016)
Figure 39 Acquisitions, By Company (2013–2016)
Figure 40 Expansions, By Company (2013–2016)
Figure 41 New Product Launches, By Company (2013–2016)
Figure 42 Other Strategies, By Company (2013–2016)
Figure 43 Geographic Revenue Mix of Top Market Players
Figure 44 Charles River Laboratories International, Inc.: Company Snapshot
Figure 45 Laboratory Corporation of America Holdings: Company Snapshot
Figure 46 Genoway S.A.: Company Snapshot
Figure 47 Horizon Discovery Group PLC: Company Snapshot

The global rat model market is projected to reach USD 588.9 Million by 2021 from 387.7 Million in 2016, growing at a CAGR of 8.7% during the forecast period. Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth.

The global market is categorized on the basis of model type, service, therapeutic area, technology, end user, care product, and region. On the basis of model type, the market is categorized into outbred rat, inbred rats, knockout/genetically modified rats, conditioned/surgically modified rats, hybrid/congenic rats, and immunodeficient rats. In 2016, the outbred rats segment is estimated to account for the largest share of the global market. However, the knockout/genetically modified rats segment is expected to be the fastest-growing segment owing to the use of this type of rat models to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s disease.

In 2016, the breeding services segment is expected to command the largest share of the market, by services. However, the cryopreservation services segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the fact that cryopreservation services help in obtaining the genetic material of rats even after the reproductive lifespan of these rats. This cuts down the time and cost needed for regenerating the rat models. In 2016, the CRISPR segment is expected to command the largest share of the global market, by technology. The large share of this segment can be attributed to its ease of use and ability to multiply.

On the basis of therapeutic area, the market is segmented into toxicology, oncology, immunology & inflammation, diabetes, neurology, and other therapeutic areas (rare diseases, cardiovascular diseases, metabolic diseases, hematopoiesis, and renal disorders). In 2016, the toxicology segment is expected to command the largest share of the global market.

On the basis of end user, the rat model market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). In 2016, the pharmaceutical & biotechnology companies segment is expected to command the largest share of the global market. However, the academic & research institutions segment is expected to grow at the highest CAGR during the forecast period.

On the basis of care product, the market is segmented into bedding, cages, feed, and other products (gnotobiotic equipment, water systems, water purification systems, and sound absorption panels). In 2016, the cages segment is expected to command the largest share of the market.

In 2016, North America is expected to account for the largest share of the global rat model market. North America’s leadership in this market can be attributed to the revised funding plans by NIH to enhance reproducibility of results, rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, and growing stem cell research in Canada. In the coming years, the rat models market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to less stringent regulations on the use of animal models for research in the region, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical and biotechnology R&D activities.

Rat Model Market

The key players in the global rat model market include Charles River Laboratories International, Inc. (U.S.), Envigo (U.K.), and Taconic Biosciences, Inc. (U.S.). Other players include Horizon Discovery Group plc (U.K.), genOway SA (France), Laboratory Corporation of America Holdings (U.S.), Transposagen Biopharmaceuticals, Inc. (U.S.), Transviragen, Inc. (U.S.), Janvier Labs (France), and Biomere (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo